Jasper Therapeutics Stock Performance
| JSPRW Stock | USD 0.22 0 0.91% |
Jasper Therapeutics holds a performance score of 9 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.25, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Jasper Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Jasper Therapeutics is expected to be smaller as well. Use Jasper Therapeutics potential upside, as well as the relationship between the accumulation distribution and price action indicator , to analyze future returns on Jasper Therapeutics.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Jasper Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Jasper Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Disposition of tradable shares by Mahal Jeetinder Singh of Jasper Therapeutics subject to Rule 16b-3 | 09/18/2024 |
2 | Insider Trading | 09/20/2024 |
| Begin Period Cash Flow | 38.7 M |
Jasper |
Jasper Therapeutics Relative Risk vs. Return Landscape
If you would invest 22.00 in Jasper Therapeutics on August 24, 2024 and sell it today you would earn a total of 0.00 from holding Jasper Therapeutics or generate 0.0% return on investment over 90 days. Jasper Therapeutics is currently producing 17.0314% returns and takes up 138.4701% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Jasper, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Jasper Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jasper Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Jasper Therapeutics, and traders can use it to determine the average amount a Jasper Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.123
| Best Portfolio | Best Equity | JSPRW | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 138.47 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Jasper Therapeutics is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jasper Therapeutics by adding it to a well-diversified portfolio.
Jasper Therapeutics Fundamentals Growth
Jasper Stock prices reflect investors' perceptions of the future prospects and financial health of Jasper Therapeutics, and Jasper Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Jasper Stock performance.
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.41 | ||||
| EBITDA | (64.98 M) | ||||
| Net Income | (64.47 M) | ||||
| Cash And Equivalents | 16.76 M | ||||
| Cash Per Share | 1.65 X | ||||
| Total Debt | 2.79 M | ||||
| Debt To Equity | 0.22 % | ||||
| Current Ratio | 1.96 X | ||||
| Book Value Per Share | 5.58 X | ||||
| Cash Flow From Operations | (52.07 M) | ||||
| Earnings Per Share | (3.84) X | ||||
| Total Asset | 94.89 M | ||||
| Retained Earnings | (169.6 M) | ||||
| Working Capital | 76.56 M | ||||
About Jasper Therapeutics Performance
Evaluating Jasper Therapeutics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Jasper Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Jasper Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (406.40) | (386.08) | |
| Return On Tangible Assets | (0.68) | (0.71) | |
| Return On Capital Employed | (0.83) | (0.88) | |
| Return On Assets | (0.68) | (0.71) | |
| Return On Equity | (0.82) | (0.78) |
Things to note about Jasper Therapeutics performance evaluation
Checking the ongoing alerts about Jasper Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Jasper Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Jasper Therapeutics is way too risky over 90 days horizon | |
| Jasper Therapeutics has some characteristics of a very speculative penny stock | |
| Jasper Therapeutics appears to be risky and price may revert if volatility continues | |
| Jasper Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (64.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Jasper Therapeutics has accumulated about 16.76 M in cash with (52.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Jasper Therapeutics has a frail financial position based on the latest SEC disclosures |
- Analyzing Jasper Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Jasper Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Jasper Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Jasper Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Jasper Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Jasper Therapeutics' stock. These opinions can provide insight into Jasper Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.